Tuixent Escribà Bel
Tuixent Escribà obtained an advanced vocational certificate as a clinical diagnostics laboratory technician from Guineueta Secondary School (Barcelona) in 2007. She obtained practical work experience in the Hospital Clínic de Barcelona Toxicology Laboratory and also worked as a technician for the Vall d’Hebron Blood and Tissue Bank. For ten years (2007-2018) she worked in the IDIBAPS HIV Immunopathogenesis and Retrovirology Laboratory at Hospital Clínic de Barcelona, specifically in the HIV Pharmacogenomics and Genomics and HIV Nucleoprotein Architecture areas. She currently forms part of the IrsiCaixa Host Genetics and Cellular Immunity research group, led by Christian Brander, where she is involved in several projects.
Impact of ChAdOx1 or DNA Prime Vaccination on Magnitude, Breadth, and Focus of MVA-Boosted Immunogen-Specific T Cell Responses.
Vaccination with an HIV T-Cell Immunogen (HTI) Using DNA Primes Followed by a ChAdOx1-MVA Boost Is Immunogenic in Gut Microbiota-Depleted Mice despite Low IL-22 Serum Levels.
Vaccination with an HIV T-cell immunogen induces alterations in the mouse gut microbiota.
Administration of broadly neutralizing anti-HIV-1 antibodies at ART initiation maintains long-term CD8+ T cell immunity.
Kinetics of immune responses elicited after three mRNA COVID-19 vaccine doses in predominantly antibody-deficient individuals.